Top companies based on CAR-T cancer therapy patents 2010-2021

Published by
Matej Mikulic,
Apr 6, 2023
German company Immatics had the highest cumulative number of CAR-T cancer therapy patents in the period from 2010 to 2021. This statistic shows the leading companies based on total number of patents related to CAR-T cancer therapies between 2010 and 2021.

Leading companies based on total number of patents related to CAR-T cancer therapies between 2010 and 2021

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

November 2022

Region

United States

Survey time period

2010 to 2021

Supplementary notes

CAR-T = chimeric antigen receptor T-cell.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Patents in the United States "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Patents in the United States

Overview

6

Patents in detail

5

Utility patents

4

Industrial design

4

Plant patents

5

Patent holders

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Bristol-Myers SquibbGlobal pharmaceutical industryPharmaceutical industry in the U.S.Johnson & JohnsonRoche
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.